The United States has officially broken ground on its first commercial nuclear-power construction projects in more than a decade, marking a significant step in the country’s push to expand low-carbon energy generation and modernise its electricity infrastructure.
The project, being developed in Alabama, is part of a broader revival of interest in nuclear energy as the U.S. seeks to meet rising electricity demand while reducing greenhouse gas emissions. The new facility is expected to use advanced reactor technology designed to improve safety, efficiency, and long-term sustainability compared to older nuclear plants.
Energy officials say the initiative reflects renewed federal and private-sector confidence in nuclear power, which had seen a slowdown in new construction due to high costs, regulatory delays, and public concerns following past nuclear incidents. The current push is being supported by policy incentives aimed at accelerating clean energy deployment.
Also Read: PM Narendra Modi Says First Phase Polling Indicates BJP Surge In Bengal
The development also comes amid increasing pressure on the U.S. power grid, driven by growth in data centres, artificial intelligence infrastructure, and electrification of transport systems. Nuclear energy is being positioned as a stable, round-the-clock power source that can complement intermittent renewable energy like solar and wind.
Project developers have emphasised that the new reactors are based on next-generation designs intended to reduce construction risks and improve operational flexibility. These include enhanced passive safety systems that can automatically shut down reactors in emergency scenarios without human intervention.
The groundbreaking is being viewed as a symbolic restart for the U.S. commercial nuclear sector, which has seen limited new builds in recent decades. If completed on schedule, the project could serve as a model for future nuclear expansion across the country as part of its long-term clean energy strategy.
Also Read: Trump Explains ‘Two Ways Of Calculating’ Drug Price Cuts At Event